Werts-Pelter Samantha J, Choi Briana M, Mallahan Stephanie, Person-Rennell Nicole, Allen Alicia
Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health University of Arizona, Tucson, Arizona, USA.
Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ.
Womens Health Rep (New Rochelle). 2024 Feb 22;5(1):161-169. doi: 10.1089/whr.2023.0130. eCollection 2024.
Cigarette smoking is the most common cause of preventable cancers and other premature morbidity and mortality. Modifying hormonal patterns using hormonal contraceptives (HCs) may lead to improved smoking cessation outcomes in women, though the acceptability of this is unknown. Therefore, we explored the willingness of reproductive-age women who smoke to use HC for cessation.
A cross-sectional online survey was conducted with a convenience sample of reproductive-age women living in the United States who self-reported smoking combustible cigarettes. Questions covered smoking history, previous HC use, and willingness to use various HC methods (., injectable, oral, patch, vaginal insert) for cessation. Chi-squared tests and logistic regression were conducted using StataBE 17.1.
Of 358 eligible respondents, = 312 (86.9%) reported previous HC use. Average age of those with HC use history was 32.1 ± 6.1 years compared with 27.8 ± 6.7 years for those without history of HC use ( = 0.001). Of respondents who reported previous HC use, 75.6% reported willingness to use HCs, compared with 60.9% of those without a history of HC use. Overall, willingness to use various types of HC ranged from 22.6% for the vaginal insert to 59.2% willing to use an oral contraceptive.
These observations indicate that most women who smoke cigarettes are willing to use HC for a smoking cessation aid, especially if they have a history of HC use and with an oral form of HC. To improve the rate of smoking cessation for women of reproductive age, future interventions should explore how to incorporate HC for cessation.
吸烟是可预防癌症以及其他过早发病和死亡的最常见原因。使用激素避孕药(HCs)改变激素模式可能会提高女性戒烟的成功率,不过其可接受性尚不清楚。因此,我们探讨了吸烟的育龄妇女使用HCs戒烟的意愿。
对居住在美国的自我报告吸燃香烟的育龄妇女进行了一项横断面在线调查,采用便利抽样。问题涵盖吸烟史、以前使用HCs的情况以及使用各种HCs方法(如注射剂、口服药、贴片、阴道栓剂)戒烟的意愿。使用StataBE 17.1进行卡方检验和逻辑回归分析。
在358名符合条件的受访者中,312人(86.9%)报告曾使用过HCs。有HCs使用史的人的平均年龄为32.1±6.1岁,而没有HCs使用史的人的平均年龄为27.8±6.7岁(P = 0.001)。在报告曾使用过HCs的受访者中,75.6%表示愿意使用HCs,而没有HCs使用史的受访者中这一比例为60.9%。总体而言,使用各种类型HCs的意愿从阴道栓剂的22.6%到愿意使用口服避孕药的59.2%不等。
这些观察结果表明,大多数吸烟女性愿意使用HCs来辅助戒烟,特别是如果她们有HCs使用史且愿意使用口服形式的HCs。为提高育龄女性的戒烟率,未来的干预措施应探索如何将HCs纳入戒烟方案。